Jennifer Dean

Jennifer Dean

Auto-generated profile, based on publicly available information

Jennifer Dean

Cancer and Blood Disorders Institute, Johns Hopkins All Children’s Hospital, St. Petersburg, Florida

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2025
Verified
Other
Open access
XYXin Yang
Xin Yang
MMMaua Mosha
Maua Mosha
DBDave Bell
Dave Bell
JDJennifer Dean
Jennifer Dean
JMJennifer Mayer
Jennifer Mayer
EAErnest K. Amankwah
Ernest K. Amankwah
Prevalence of comorbidity groups among pediatric patients with ALL/LL. Proportion of pediatric patients with ALL/LL with different groups of comorbidities. Error bars indicate 95% CI.

15 May 2025
Verified
Other
Open access
XYXin Yang
Xin Yang
MMMaua Mosha
Maua Mosha
DBDave Bell
Dave Bell
JDJennifer Dean
Jennifer Dean
JMJennifer Mayer
Jennifer Mayer
EAErnest K. Amankwah
Ernest K. Amankwah
Limited knowledge exists on the prevalence of comorbidity among pediatric patients diagnosed with acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma (LL). To determine the prevalence of comorbidities present within 3 months before diagnosis among pediatric patients with ALL/LL and to examine if the prevalence varies by age, biological sex at birth, and race/ethnicity, we analyzed data of patients diagnosed with ALL/LL at ≤21 years of age from January 1, 2005, to June 30, 2020 (n = 5,455), using electronic health records data from the TriNetX Research Network database. Comorbidities examined included pulmonary, cardiac, cerebrovascular, vascular, developmental, immune, metabolic, infectious, genitourinary, digestive, muscle and connective tissue and central and peripheral nervous system conditions. Overall, the prevalence of comorbidity was 34.1% (n = 1,904), with significant differences observed based on sex and race/ethnicity. Females had a higher prevalence at 36.6% compared with males at 33.6% (P = 0.024). Similarly, non-Hispanic White patients had a higher prevalence of 37.5% compared with 33.1% in other racial/ethnic groups (P < 0.001). Analyses of specific comorbidities revealed notable differences in the prevalence of infectious diseases by biological sex at birth (female: 9.7%, male: 7.0%; P < 0.001) and digestive diseases by age at diagnosis (≤10 years: 13.8%, >10 years: 10.4%; P < 0.001). Although the overall prevalence of comorbidity at diagnosis showed minor differences across groups, disparities exist for specific comorbidities with females and younger patients having a higher prevalence of infectious diseases and digestive tract diseases, respectively. Future studies are needed to evaluate if these differences contribute to the disparities in treatment outcomes.Significance:Among pediatric patients with ALL/LL, significant disparities were found for specific comorbidities, particularly among females and younger patients who had higher rates of digestive tract diseases and infectious diseases. These findings are important as comorbidities can be considered in clinical decision-making in the management and treatment of these patients.

13 May 2025
Verified
Other
Open access
XYXin Yang
Xin Yang
MMMaua Mosha
Maua Mosha
DBDave Bell
Dave Bell
JDJennifer Dean
Jennifer Dean
JMJennifer Mayer
Jennifer Mayer
EAErnest K. Amankwah
Ernest K. Amankwah
Top 10 common diagnosis in genitourinary diseases (with each diagnosis code counted once per patient within the 3 months prior to their ALL/LL diagnosis, regardless of multiple occurrences)

15 May 2025
Verified
Other
Open access
XYXin Yang
Xin Yang
MMMaua Mosha
Maua Mosha
DBDave Bell
Dave Bell
JDJennifer Dean
Jennifer Dean
JMJennifer Mayer
Jennifer Mayer
EAErnest K. Amankwah
Ernest K. Amankwah
Supplementary Table S1 shows the ICD-9/10-CM codes for used for identifying patients with ALL/LL and comorbidities

1 April 2025
Verified
Other
Open access
XYXin Yang
Xin Yang
MMMaua Mosha
Maua Mosha
DBDave Bell
Dave Bell
JDJennifer Dean
Jennifer Dean
JMJennifer Mayer
Jennifer Mayer
EAErnest K. Amankwah
Ernest K. Amankwah
Prevalence of comorbidity by biological sex at birth among pediatric patients with ALL/LL. Proportion of female and male pediatric patients with ALL/LL with comorbidities. Error bars indicate 95% CI. F, female; M, male.

2 April 2025
Verified
Other
Open access
XYXin Yang
Xin Yang
MMMaua Mosha
Maua Mosha
DBDave Bell
Dave Bell
JDJennifer Dean
Jennifer Dean
JMJennifer Mayer
Jennifer Mayer
EAErnest K. Amankwah
Ernest K. Amankwah
Top 10 common diagnosis in digestive tract disorders (with each diagnosis code counted once per patient within the 3 months prior to their ALL/LL diagnosis, regardless of multiple occurrences)